| 51 |
21129805 | Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. | 2011 Mar |
1 |
| 52 |
21147189 | IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. | 2011 Aug |
2 |
| 53 |
21228123 | IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations. | 2011 May |
1 |
| 54 |
21360545 | Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b. | 2011 May |
3 |
| 55 |
21374656 | IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. | 2011 Mar |
1 |
| 56 |
21389156 | The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B. | 2011 May |
1 |
| 57 |
21739446 | Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene. | 2011 Sep |
1 |
| 58 |
21817190 | Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirin. | 2011 |
1 |
| 59 |
21907615 | Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin. | 2011 Dec |
1 |
| 60 |
21972552 | [Genome-wide association study on and the clinical application to chronic hepatitis C]. | 2011 Jun |
1 |
| 61 |
22156487 | Association of interleukin-28B and hepatitis C genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapy. | 2011 |
1 |
| 62 |
22977564 | Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapy. | 2011 Jul |
2 |
| 63 |
20648473 | Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. | 2010 Aug |
3 |
| 64 |
20708617 | Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. | 2010 Nov |
2 |